Asian Phytoceuticals Stock

Equities

APCO

TH1077A10Z09

Personal Products

End-of-day quote Thailand S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
6.45 THB +4.03% Intraday chart for Asian Phytoceuticals +15.18% +24.04%
Sales 2022 250M 6.8M Sales 2023 293M 7.95M Capitalization 3.12B 84.76M
Net income 2022 80M 2.17M Net income 2023 107M 2.91M EV / Sales 2022 11.3 x
Net cash position 2022 165M 4.49M Net cash position 2023 216M 5.86M EV / Sales 2023 9.92 x
P/E ratio 2022
37.1 x
P/E ratio 2023
29 x
Employees -
Yield 2022
3.1%
Yield 2023
3.46%
Free-Float 19.89%
More Fundamentals * Assessed data
Dynamic Chart
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Asian Phytoceuticals Public Company Limited Approves Dividend for the Year 2023, Payable on May 13, 2024 CI
Asian Phytoceuticals Public Company Limited Proposes Dividend, Payable on May 13, 2024 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Asian Phytoceuticals Public Company Limited Approves Dividend, Payable on May 22, 2023 CI
Asian Phytoceuticals Public Company Limited Appoints Montien Sirisoonthornlak as Director CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Asian Phytoceuticals Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Asian Phytoceuticals Public Company Limited Approves Dividend, Payable on May 9, 2022 CI
Asian Phytoceuticals Public Company Limited Announces the Establishment of Companies CI
More news
1 day+4.03%
1 week+15.18%
1 month+32.72%
3 months+30.04%
6 months+26.47%
Current year+24.04%
More quotes
1 week
5.55
Extreme 5.55
6.50
1 month
4.82
Extreme 4.82
6.50
Current year
4.82
Extreme 4.82
6.50
1 year
4.76
Extreme 4.76
7.20
3 years
3.74
Extreme 3.74
8.20
5 years
2.68
Extreme 2.68
8.20
10 years
2.68
Extreme 2.68
17.38
More quotes
Managers TitleAgeSince
Founder 80 88-06-01
Director of Finance/CFO 56 11-11-10
Chief Tech/Sci/R&D Officer 58 08-12-31
Members of the board TitleAgeSince
Director/Board Member 75 11-04-29
Director/Board Member 82 04-12-31
Chairman 79 11-04-29
More insiders
Date Price Change Volume
24-05-31 6.45 +4.03% 1,984,213
24-05-30 6.2 +0.81% 863,753
24-05-29 6.15 +6.03% 1,529,661
24-05-28 5.8 +1.75% 1,086,730
24-05-27 5.7 +1.79% 704,169

End-of-day quote Thailand S.E., May 30, 2024

More quotes
Asian Phytoceuticals Public Company Limited is a Thailand-based company, which is engaged in business of research and development, manufacturing, and distribution of its products for health and natural beauty. It operates through the manufacturing and distribution of dietary supplements from herbs. The Company’s products and brands include operation balancing immunity (BIM), longevity, and slimming and beauty products. Its operation BIM includes Mylife, LIV Capsule, Garcinia, Arthrinox, Diabenok, Tumorid capsule, Noriasis, Canvirol and others. The Company’s slimming products include Asian Life Revitalizing Serum, Asian Life Revitalizing Cream, Garcinia Acne Cream, Garcinia Facial Cleansing Gel, Garcinia Cleansing Cream, Noriasis Nourishing Skin Cream, and others. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
More about the company